Allergy medication recalled over potentially ‘life-threatening’ cross-contamination

Unique Pharmaceutical Laboratories has issued a voluntary nationwide recall for specific lots of cetirizine hydrochloride tablets. This action follows reports of potential cross-contamination with ranitidine, a medication formerly used for ulcers and heartburn.

While cetirizine is a common treatment for allergy symptoms like runny nose, sneezing, and watery eyes, the presence of ranitidine poses a significant health risk to certain users. The FDA notes that some individuals may experience serious hypersensitivity reactions or anaphylaxis when exposed to this unintended substance. Potential life-threatening symptoms include difficulty breathing, severe swelling in the face or throat, and sudden drops in blood pressure.

Company officials identified the issue after a pharmacy technician observed physical irregularities, specifically red or discolored tablets, during routine inspections. Although no reports of illness or injury have surfaced at this time, the company is moving forward with the return process to ensure consumer safety.

The recall covers four specific lots of 5 mg cetirizine hydrochloride tablets packaged in 100-count bottles. These products were distributed by Rising Pharma Holdings Inc. Consumers who possess these specific bottles should check their lot numbers against the list provided by the manufacturer. You can verify your product information by checking the packaging for lot numbers GY825029, GY825030, GY825031, or GY825032. All recalled bottles share an expiration date of October 2028.

Rising Pharma Holdings Inc. has initiated outreach to affected customers via email to facilitate the return of these items. If you have questions regarding the recall or need to arrange a return, you can contact the company directly at 1-844-874-7464. Alternatively, inquiries can be sent to pv@risingpharma.com or qa@risingpharma.com. It remains important to verify your medication supply and consult a healthcare professional if you suspect you possess impacted tablets.